JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total Bond Market
BND
|
+$2.29B |
| 2 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$2.1B |
| 3 |
Vanguard Total International Bond ETF
BNDX
|
+$1.67B |
| 4 |
AbbVie
ABBV
|
+$1.6B |
| 5 |
ExxonMobil
XOM
|
+$1.5B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Short-Term Bond ETF
BSV
|
+$3.99B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.33B |
| 3 |
Vanguard Short-Term Treasury ETF
VGSH
|
+$1.15B |
| 4 |
Tesla
TSLA
|
+$1.05B |
| 5 |
iShares TIPS Bond ETF
TIP
|
+$1.04B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.04% |
| 2 | Healthcare | 10.96% |
| 3 | Financials | 10.87% |
| 4 | Consumer Discretionary | 8.6% |
| 5 | Industrials | 7.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3301
Trupanion
TRUP
$1.34B
| $2.94M | ﹤0.01% |
33,002
+4,481
| +16% | +$412K |
|
3302
Under Armour Class C
UA
$2.26B
| $2.94M | ﹤0.01% |
188,972
-119,049
| -39% | -$1.86M |
|
|
JAQC
3303
DELISTED
Jupiter Acquisition Corporation Common stock
JAQC
| $2.94M | ﹤0.01% |
304,950
-2,000
| -0.7% | -$19.2K |
|
3304
Mueller Water Products
MWA
$3.99B
| $2.93M | ﹤0.01% |
226,706
-65,617
| -22% | -$847K |
|
3305
InMode
INMD
$872M
| $2.93M | ﹤0.01% |
79,333
+43,646
| +122% | +$1.95M |
|
3306
State Street SPDR Dow Jones REIT ETF
RWR
$1.89B
| $2.93M | ﹤0.01% |
24,957
-975
| -4% | -$111K |
|
|
FVIV
3307
DELISTED
Fortress Value Acquisition Corp. IV
FVIV
| $2.92M | ﹤0.01% |
+298,432
| New | +$2.91M |
|
|
SHOE
3308
Shoe Station Group
SHOE
$414M
| $2.92M | ﹤0.01% |
100,133
+13,912
| +16% | +$454K |
|
|
HPLT
3309
DELISTED
Home Plate Acquisition Corporation Class A Common Stock
HPLT
| $2.92M | ﹤0.01% |
300,000
+2,000
| +0.7% | +$19.4K |
|
3310
Methanex
MEOH
$4.34B
| $2.91M | ﹤0.01% |
53,409
+34,223
| +178% | +$1.67M |
|
3311
CALL
Lattice Semiconductor
LSCC
$18.5B
| $2.91M | ﹤0.01% |
+47,700
| New | +$2.86M |
|
3312
Sylvamo
SLVM
$1.53B
| $2.9M | ﹤0.01% |
87,208
+58,413
| +203% | +$1.94M |
|
3313
PUT
SoFi Technologies
SOFI
$23.6B
| $2.89M | ﹤0.01% |
+306,000
| New | +$3.51M |
|
3314
Martin Midstream Partners
MMLP
$93.9M
| $2.89M | ﹤0.01% |
688,103
-30,332
| -4% | -$103K |
|
3315
PUT
Marvell Technology
MRVL
$199B
| $2.89M | ﹤0.01% |
40,300
-10,000
| -20% | -$720K |
|
|
ADAP
3316
DELISTED
Adaptimmune Therapeutics
ADAP
| $2.88M | ﹤0.01% |
1,399,765
-78,273
| -5% | -$211K |
|
3317
CALL
Henry Schein
HSIC
$10B
| $2.88M | ﹤0.01% |
+33,000
| New | +$2.69M |
|
3318
Methode Electronics
MEI
$608M
| $2.88M | ﹤0.01% |
66,517
-1,935
| -3% | -$86.7K |
|
|
SILK
3319
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $2.87M | ﹤0.01% |
69,559
-337
| -0.5% | -$11.9K |
|
3320
Lifestance Health
LFST
$4.75B
| $2.87M | ﹤0.01% |
283,852
+8,624
| +3% | +$75.7K |
|
3321
Taysha Gene Therapies
TSHA
$1.94B
| $2.87M | ﹤0.01% |
439,804
+202,245
| +85% | +$1.51M |
|
3322
CALL
PNC Financial Services
PNC
$103B
| $2.86M | ﹤0.01% |
15,500
+4,900
| +46% | +$991K |
|
|
TPC
3323
Tutor Perini Cor
TPC
$5.09B
| $2.85M | ﹤0.01% |
264,162
-74,121
| -22% | -$831K |
|
3324
Lineage Cell Therapeutics
LCTX
$271M
| $2.85M | ﹤0.01% |
1,849,662
+566,385
| +44% | +$879K |
|
3325
Global X Silver Miners ETF NEW
SIL
$4.79B
| $2.85M | ﹤0.01% |
78,290
-18,996
| -20% | -$673K |
|
Similar funds
JP Morgan Chase's Q1 2022 Portfolio in Review
As of Q1 2022, JP Morgan Chase held 7,378 positions worth $830B, down 4.1% from $866B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q1 2022 filing shows 607 new, 2,657 increased, 2,665 reduced and 679 closed positions. Its largest new stake was iShares AAA-A Rated Corporate Bond ETF: 4,681,132 shares worth $243M. The largest sale was Vanguard Short-Term Bond ETF, an estimated $3.99B.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 17% a quarter earlier, followed by Healthcare and Financials.
- JP Morgan Chase's largest Q1 2022 buy was iShares AAA-A Rated Corporate Bond ETF: 4,681,132 shares worth $243M.
- JP Morgan Chase added most to Vanguard Total Bond Market in Q1 2022, an estimated $2.29B increase.
- JP Morgan Chase's biggest Q1 2022 reduction was Vanguard Short-Term Bond ETF, cutting an estimated $3.99B.
- JP Morgan Chase fully exited IHS Markit Ltd. Common Shares in Q1 2022, selling an estimated $442M.
- JP Morgan Chase's ten largest holdings make up 18% of its $830B portfolio in Q1 2022.
- JP Morgan Chase opened 607 new positions and closed 679 in Q1 2022.
- JP Morgan Chase's portfolio value fell 4.1% quarter-over-quarter to $830B.
Based on JP Morgan Chase's 13F filing for Q1 2022, filed 11 May 2022.